These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36278459)
21. Proniosomes in transdermal drug delivery. Rahimpour Y; Kouhsoltani M; Hamishehkar H Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111 [TBL] [Abstract][Full Text] [Related]
22. Proniosomes: a novel drug carrier preparation. Hu C; Rhodes DG Int J Pharm; 1999 Aug; 185(1):23-35. PubMed ID: 10425362 [TBL] [Abstract][Full Text] [Related]
23. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Abdelkader H; Alani AW; Alany RG Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390 [TBL] [Abstract][Full Text] [Related]
24. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Abd-Elbary A; El-laithy HM; Tadros MI Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494 [TBL] [Abstract][Full Text] [Related]
25. Formulation and characterization of catechin-loaded proniosomes for food fortification. Shruthi PA; Pushpadass HA; Magdaline Eljeeva Emerald F; Surendra Nath B; Laxmana Naik N J Sci Food Agric; 2021 Apr; 101(6):2439-2448. PubMed ID: 33027542 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol proniosomes as a convenient nanoingredient for functional food. Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712 [TBL] [Abstract][Full Text] [Related]
27. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Aburahma MH; Abdelbary GA Int J Pharm; 2012 Jan; 422(1-2):139-50. PubMed ID: 22079716 [TBL] [Abstract][Full Text] [Related]
28. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability. Zidan AS; Mokhtar Ibrahim M; Megrab NAE Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295 [TBL] [Abstract][Full Text] [Related]
29. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation. Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876 [TBL] [Abstract][Full Text] [Related]
30. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729 [TBL] [Abstract][Full Text] [Related]
31. A Compendium of Bioavailability Enhancement Sharma S; Kumari N; Garg D; Chauhan S Pharm Nanotechnol; 2023; 11(4):324-338. PubMed ID: 36892113 [TBL] [Abstract][Full Text] [Related]
32. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Blazek-Welsh AI; Rhodes DG Pharm Res; 2001 May; 18(5):656-61. PubMed ID: 11465422 [TBL] [Abstract][Full Text] [Related]
33. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Mokhtar M; Sammour OA; Hammad MA; Megrab NA Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437 [TBL] [Abstract][Full Text] [Related]
34. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations. Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402 [TBL] [Abstract][Full Text] [Related]
35. Methods for preparation of niosomes: A focus on thin-film hydration method. Thabet Y; Elsabahy M; Eissa NG Methods; 2022 Mar; 199():9-15. PubMed ID: 34000392 [TBL] [Abstract][Full Text] [Related]
36. Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects. Li D; Martini N; Liu M; Falconer JR; Locke M; Wu Z; Wen J J Drug Target; 2021 Mar; 29(3):310-322. PubMed ID: 33044095 [TBL] [Abstract][Full Text] [Related]
37. Niosomes: a controlled and novel drug delivery system. Rajera R; Nagpal K; Singh SK; Mishra DN Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996 [TBL] [Abstract][Full Text] [Related]
38. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Moghassemi S; Hadjizadeh A J Control Release; 2014 Jul; 185():22-36. PubMed ID: 24747765 [TBL] [Abstract][Full Text] [Related]
39. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Yasamineh S; Yasamineh P; Ghafouri Kalajahi H; Gholizadeh O; Yekanipour Z; Afkhami H; Eslami M; Hossein Kheirkhah A; Taghizadeh M; Yazdani Y; Dadashpour M Int J Pharm; 2022 Aug; 624():121878. PubMed ID: 35636629 [TBL] [Abstract][Full Text] [Related]
40. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. El-Laithy HM; Shoukry O; Mahran LG Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]